| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.72▼ | 1.72▼ | 1.72▼ | 1.72▼ | 1.63▲ |
| MA10 | 1.72▼ | 1.71▲ | 1.72▼ | 1.66▲ | 1.70▼ |
| MA20 | 1.72▼ | 1.72▼ | 1.74▼ | 1.69▲ | 1.85▼ |
| MA50 | 1.73▼ | 1.73▼ | 1.68▲ | 1.79▼ | 2.17▼ |
| MA100 | 1.74▼ | 1.66▲ | 1.64▲ | 1.91▼ | 1.87▼ |
| MA200 | 1.73▼ | 1.66▲ | 1.76▼ | 2.28▼ | 3.62▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | -0.007▼ | 0.017▲ | -0.010▼ |
| RSI | 48.351▼ | 48.325▼ | 49.129▼ | 48.640▼ | 45.312▼ |
| STOCH | 35.000 | 67.500 | 51.051 | 67.755 | 30.783 |
| WILL %R | -70.000 | -35.000 | -55.172 | -38.710 | -61.745 |
| CCI | -63.348 | 6.943 | -65.828 | 58.333 | -38.389 |
| ▼ GAP | $IKT Open Gap Down %2 | Set Alert |
|
Tuesday, August 19, 2025 05:11 AM
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”) ...
|
|
Thursday, August 14, 2025 06:53 PM
Expenses rose sharply due to pipeline investments and acquisition effects, leading to a GAAP net loss of $9.9 million, up from $5.0 million in Q2 2024. However, it ended the period with $87.7 million ...
|
|
Thursday, August 14, 2025 02:11 PM
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ('Inhibikase” or 'Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/08/25 | 1.68 | 1.85 | 1.65 | 1.70 | 89,865 |
| 18/08/25 | 1.74 | 1.8567 | 1.72 | 1.72 | 57,147 |
| 15/08/25 | 1.75 | 1.85 | 1.625 | 1.75 | 143,575 |
| 14/08/25 | 1.70 | 1.795 | 1.61 | 1.71 | 81,201 |
| 13/08/25 | 1.77 | 1.88 | 1.695 | 1.71 | 131,235 |
| 12/08/25 | 1.53 | 1.7982 | 1.53 | 1.75 | 167,813 |
| 11/08/25 | 1.46 | 1.52 | 1.44 | 1.51 | 48,252 |
| 08/08/25 | 1.55 | 1.56 | 1.415 | 1.43 | 142,885 |
| 07/08/25 | 1.74 | 1.74 | 1.54 | 1.55 | 136,153 |
| 06/08/25 | 1.78 | 1.78 | 1.6901 | 1.73 | 82,089 |
|
|
||||
|
|
||||
|
|